Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Danish Pain Research Center Pfizer |
---|---|
Information provided by: | Danish Pain Research Center |
ClinicalTrials.gov Identifier: | NCT00169013 |
To investigate whether gabapentin can prevent phantom and stump pain after amputation.
Condition | Intervention | Phase |
---|---|---|
Amputation of Lower Limb |
Drug: Gabapentin |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Gabapentin in the Prevention of Phantom Limb Pain |
Study Start Date: | May 2002 |
Estimated Study Completion Date: | June 2006 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
1. Amputation of crus or femur
Exclusion Criteria:
Denmark | |
Danish Pain Research Center, Aarhus University Hospital | |
Aarhus, Denmark, 8000 |
Principal Investigator: | Lone Nikolajsen, MD, PhD | Danish Pain Research Center |
Study ID Numbers: | Gabapentin2002 |
Study First Received: | September 9, 2005 |
Last Updated: | April 11, 2007 |
ClinicalTrials.gov Identifier: | NCT00169013 |
Health Authority: | Denmark: Danish Medicines Agency |
Excitatory Amino Acids Calcium, Dietary Gabapentin Pain Phantom Limb |
Neurotransmitter Agents Tranquilizing Agents Molecular Mechanisms of Pharmacological Action Anti-Dyskinesia Agents Physiological Effects of Drugs Psychotropic Drugs Central Nervous System Depressants Antiparkinson Agents Calcium Channel Blockers Excitatory Amino Acid Agents Cardiovascular Agents |
Antimanic Agents Pharmacologic Actions Membrane Transport Modulators Sensory System Agents Therapeutic Uses Anti-Anxiety Agents Analgesics Peripheral Nervous System Agents Central Nervous System Agents Anticonvulsants Excitatory Amino Acid Antagonists |